Trademark: 86374590
Word
RNARCHITECTURE
Status
Dead
Status Code
606
Status Date
Monday, June 19, 2017
Serial Number
86374590
Mark Type
4000
Filing Date
Friday, August 22, 2014
Published for Opposition
Tuesday, March 22, 2016
Abandoned Date
Monday, June 19, 2017

Trademark Owner History
CUREVAC AG - 1st New Owner After Publication
CureVac GmbH - Owner At Publication

Classifications
1 CHEMICAL REAGENTS AND BIOMOLECULES, IN PARTICULAR BIOLOGICAL MACROMOLECULES FOR INDUSTRY AND SCIENCE, REAGENTS FOR RESEARCH PURPOSES, ALL OF THE FOREGOING BEING GOODS WHICH TARGET OR WORK WITH RNA
5 CHEMICAL PREPARATIONS FOR PHARMACEUTICAL OR MEDICAL PURPOSES, NAMELY, FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMOURS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; PHARMACEUTICAL AND VETERNARY MEDICAL PREPARATIONS FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMOURS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; IMMUNOSTIMULATORY COMPOSITIONS; VACCINES, ADJUVANT IMMUNOSTIMULANTS; PHARMACEUTICALS AND MEDICAMENTS BASED ON/CONTAINING/PREPARED FROM BIOLOGICAL MACROMOLECULES FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMOURS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; GENE THERAPY PRODUCTS, NAMELY, NUCLEIC ACID MACROMOLECULES FOR IN VIVO EXPRESSION; FOOD SUPPLEMENTS FOR MEDICAL USE, ALL OF THE FOREGOING BEING GOODS WHICH TARGET OR WORK WITH RNA
44 MEDICAL AND VETERINARY SERVICES, IN PARTICULAR FOR THERAPEUTIC AND PROPHYLACTIC TREATMENT OF TUMOR DISEASES, INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND ALLERGIES, FOR THE TREATMENT OF HEREDITARY DISORDERS AND FOR PROTEIN OR ENZYME SUPPLEMENT THERAPY, FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISORDERS AND FOR THE TREATMENT OF ENDOCRINOLOGICAL DISORDERS

Trademark Events
Jun 19, 2017
Abandonment Notice Mailed - No Use Statement Filed
Jun 19, 2017
Abandonment - No Use Statement Filed
Nov 23, 2016
Automatic Update Of Assignment Of Ownership
Oct 4, 2016
Notice Of Approval Of Extension Request E-Mailed
Sep 30, 2016
Extension 1 Granted
Sep 30, 2016
Extension 1 Filed
Sep 30, 2016
Teas Extension Received
May 17, 2016
Noa E-Mailed - Sou Required From Applicant
Mar 22, 2016
Official Gazette Publication Confirmation E-Mailed
Mar 22, 2016
Published For Opposition
Mar 2, 2016
Notification Of Notice Of Publication E-Mailed
Feb 17, 2016
Law Office Publication Review Completed
Feb 8, 2016
Approved For Pub - Principal Register
Feb 2, 2016
Teas/Email Correspondence Entered
Feb 2, 2016
Correspondence Received In Law Office
Feb 2, 2016
Teas Response To Office Action Received
Sep 16, 2015
Notification Of Non-Final Action E-Mailed
Sep 16, 2015
Non-Final Action E-Mailed
Sep 16, 2015
Non-Final Action Written
Aug 3, 2015
Previous Allowance Count Withdrawn
Jul 28, 2015
Withdrawn From Pub - Og Review Query
Jul 14, 2015
Law Office Publication Review Completed
Jul 8, 2015
Assigned To Lie
Jun 23, 2015
Approved For Pub - Principal Register
Jun 17, 2015
Teas/Email Correspondence Entered
Jun 16, 2015
Correspondence Received In Law Office
Jun 16, 2015
Teas Response To Office Action Received
Dec 16, 2014
Notification Of Non-Final Action E-Mailed
Dec 16, 2014
Non-Final Action E-Mailed
Dec 16, 2014
Non-Final Action Written
Dec 8, 2014
Assigned To Examiner
Sep 5, 2014
New Application Office Supplied Data Entered In Tram
Aug 26, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24